Thrombopoietin improves the functions of bone marrow endothelial progenitor cells via METTL16 /Akt signalling of haematological patients with chemotherapy‐induced thrombocytopenia
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19722 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Hui Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, P.R. China. Hauptthemen laut MEDLINE: Endothelial Progenitor Cells, Thrombopoietin, Thrombocytopenia, Methyltransferases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Science, Technology and Innovation Committee of Shenzhen, Guangdong Basic and Applied Basic Research Foundation, National Natural Science Foundation of China.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Bone marrow endothelial progenitor cells (BM EPCs) are crucial in supporting haematopoietic regeneration, while the BM EPCs of haematological patients with chemotherapy‐induced thrombocytopenia (CIT) are unavoidably damaged. Therefore, the present study aimed to examine the effect of thrombopoietin (TPO) on the recovery of BM EPCs of CIT patients and to identify the underlying mechanisms. The cell functions were determined by 1,1‘‐dioctadecyl‐3,3,3’,3‘‐tetramethylindocarbocyanine perchlorate (Dil)–acetylated low‐density lipoprotein (Dil‐Ac‐LDL) uptake and fluorescein isothiocyanate (FITC)‐labeled Ulex europaeus agglutinin‐I (FITC‐UEA‐I) binding assay, as well as proliferation, migration and tube formation experiments. Endothelial cells were transfected with METTL16 lentivirus, followed by methylated RNA immunoprecipitation sequencing. Zebrafish with vascular defect was used as the in vivo model. TPO significantly improved the quantity and functions of BM EPCs from CIT patients in vitro and restored the subintestinal vein area of zebrafish with vascular defect in vivo. Mechanically, TPO enhanced the BM EPC functions through Akt signal mediated by METTL16, which was downregulated in BM EPCs of CIT patients and involved in the regulation of endothelial functions. The present study demonstrates that TPO improves the recovery of BM EPCs from CIT patients with haematological malignancies via METTL16/Akt signalling, which provides new insights into the role of TPO in treating CIT in addition to direct megakaryopoiesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, P.R. China.
- Shenzhen Key Laboratory of Chinese Medicine Active Substance Screening and Translational Research, Shenzhen, Guangdong, P.R. China.
- Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, P.R. China.
- Guangdong Provincial Key Laboratory of Digestive Cancer Research, Digestive Diseases Center, Shenzhen, Guangdong, P.R. China.
- Department of Hematology, Hematology Research Institute, Affiliated Hospital of Guangdong Medical University (GDMU), Zhanjiang, China.
Förderung
- Science, Technology and Innovation Committee of Shenzhen
- Guangdong Basic and Applied Basic Research Foundation
- National Natural Science Foundation of China
- Shenzhen Key Laboratory of Chinese Medicine Active Substance Screening and Translational Research
- Sanming Project of Medicine in Shenzhen
- Basic and Applied Basic Research Foundation of Guangdong Province
- Sanming Project of Medicine in Shenzen Municipality
Zitieren
APA
Chen, H., Jiao, Y., Lin, C., Fan, W., Li, L., Li, B., Li, L., Zeng, X., Li, Z., Wei, H., Zhang, Y., Zhou, B., Chen, C., Ye, J., & Yang, M. (2024). Thrombopoietin improves the functions of bone marrow endothelial progenitor cells via METTL16 /Akt signalling of haematological patients with chemotherapy‐induced thrombocytopenia. British Journal of Haematology. https://doi.org/10.1111/bjh.19722
Vancouver
Chen H, Jiao Y, Lin C, Fan W, Li L, Li B, et al. Thrombopoietin improves the functions of bone marrow endothelial progenitor cells via METTL16 /Akt signalling of haematological patients with chemotherapy‐induced thrombocytopenia. British Journal of Haematology. 2024. doi:10.1111/bjh.19722
BibTeX
@article{Chen2024,
author = {Chen, Hui and Jiao, Yingying and Lin, Chao and Fan, Wenxuan and Li, Lindi and Li, Bo and Li, Liang and Zeng, Xiaoyuan and Li, Zongpeng and Wei, Hongfa and Zhang, Yuming and Zhou, Benjie and Chen, Chun and Ye, Jieyu and Yang, Mo},
title = {Thrombopoietin improves the functions of bone marrow endothelial progenitor cells via METTL16 /Akt signalling of haematological patients with chemotherapy‐induced thrombocytopenia},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19722}
}
EUVIMED